Related Experiment Video
Updated: Jul 3, 2026

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Expression of p14ARF, MDM2, and MDM4 in human retinoblastoma
Ying Guo1, Sanja Pajovic, Brenda L Gallie
1Division of Applied Molecular Oncology, Ontario Cancer Institute/Princess Margaret Hospital, University Health Network, Room 8-415, 610 University Avenue, Toronto, ON, Canada.
Abstract:
It is still not clear whether the p53 pathway is altered in retinoblastoma development. We assessed the expression of the p53 pathway genes p14(ARF), mouse double minute 2 (MDM2), and mouse double minute 4 (MDM4) in human retinoblastoma compared to normal retina. Primary human retinoblastomas, retinoblastoma cell lines and normal retinas were assessed for p14(ARF) and MDM4 mRNA by quantitative RT-PCR. p14(ARF), MDM2, and MDM4 protein were measured by immunoblot and immunohistochemistry. Compared to retina, p14(ARF) mRNA expression was notably increased in retinoblastoma but p14(ARF) protein was undetectable. MDM2 and MDM4 proteins were expressed in 22/22 retinoblastomas. MDM2 was expressed in 3/10 retinas tested, and MDM4 in 10/10 retinas. The expression level of MDM2 protein in retinoblastomas and retina was comparable, while MDM4 protein was overexpressed in one retinoblastoma cell line Y79 and two primary retinoblastomas. We observe that overexpression of MDM2 and MDM4 is not a necessary step in retinoblastoma development. However, loss of detectable p14(ARF) protein and resultant lack of functional inactivation of these p53 inhibitors may contribute to retinoblastoma development by constitutive inhibition of p53.
Insights
The p53 pathway
Area of Science:
- Oncology
- Molecular Biology
- Ophthalmology
Background:
- The role of the p53 pathway in retinoblastoma, a common childhood eye cancer, remains unclear.
- Key regulators of the p53 pathway, including p14(ARF), MDM2, and MDM4, are implicated in various cancers.
Purpose of the Study:
- To investigate the expression of p14(ARF), MDM2, and MDM4 in human retinoblastoma.
- To determine if alterations in these p53 pathway genes contribute to retinoblastoma development.
Main Methods:
- Quantitative RT-PCR was used to assess mRNA levels of p14(ARF) and MDM4.
- Immunoblotting and immunohistochemistry were employed to measure protein expression of p14(ARF), MDM2, and MDM4.
- Samples included primary human retinoblastomas, retinoblastoma cell lines, and normal retinas.
Main Results:
- p14(ARF) mRNA was elevated in retinoblastoma, but p14(ARF) protein was undetectable.
- MDM2 and MDM4 proteins were present in most retinoblastomas.
- MDM4 protein was overexpressed in some retinoblastomas, while MDM2 levels were comparable to normal retina.
Conclusions:
- Overexpression of MDM2 and MDM4 is not essential for retinoblastoma formation.
- Loss of detectable p14(ARF) protein may lead to p53 inhibition, potentially contributing to retinoblastoma development.
- Further research is needed to fully elucidate the p53 pathway's role in retinoblastoma.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Negative Regulator Molecules